Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs. Listen to podcast below:
Read the transcript, which includes charts, below.
Read more »
Read the transcript, which includes charts, below.
Read more »
The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians
![The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians]()
Reviewed by admin
on
May 05, 2017
Rating:
No comments: